KDR and lung cancer: Furthermore, our results showed that its soluble form, sCD146, which was increased in the serum and CSF of lung cancer patients with BrM, directly binds to VEGFR2 on ECs, stabilizing and sensitizing VEGFR2 to its ligand as a co-receptor.